Stock BLISSGVS BLISS GVS PHARMA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Bliss GVS Pharma Limited

Equities

BLISSGVS

INE416D01022

Pharmaceuticals

Delayed Bombay S.E.
Other stock markets
 03:52:00 2024-04-30 am EDT 		5-day change 1st Jan Change
128 INR +2.81% Intraday chart for Bliss GVS Pharma Limited +12.24% +2.69%
Jan. 23 Bliss GVS Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
2023 Bliss GVS Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI

Business Summary

Bliss GVS Pharma Limited is engaged in developing, manufacturing, and marketing pharmaceutical formulations. The Company’s product categories include pharma products and other healthcare products. Its pharma products include pharma products include capsules, creams, gels, ointments, dry powder for injection, effervescent tablets, eye/ear drops, nasal solution, lotions, lozenges, soft gelatine capsules and syrups. The Company’s other healthcare products include balm, nasal inhaler, solution, soap, vaginal wash, roll on, shampoo, powder, spray, and petroleum jelly. Its brands include ANOMEX, ANOMEX DS, CONLAX 5/10, G - ALFENAC 100, GACET 80/125/170/250/500/1G, GMETH - 50/100, GSUNATE - 50/100/200, GVCAM - 7.5/15, GV-SOFT 1/2/3/4 G, LOFNAC - 12.5/25/50/100, MEFINOL, MELANEZ, MENINA - 25/100, TYRIDOL, VIGOTAMIN, COMIT 50, BG - CLIND, VAGID CL, ECOZOLE, GVGYL 500, GYNANFORT, GVGYL N, KLOVINAL, LONART, LONART FORTE, LONART Dispersible, FINMOL, GACET-500, and DOXYCYCLINE.

Number of employees: 763

Sales per Business

INR in Million2022Weight2023Weight Delta
Pharmaceuticals
100.0 %
7,379 100.0 % 7,474 100.0 % +1.29%

Sales per region

INR in Million2022Weight2023Weight Delta
International
94.8 %
6,817 92.4 % 7,083 94.8 % +3.90%
India
5.2 %
562 7.6 % 392 5.2 % -30.36%

Managers

Managers TitleAgeSince
Gagan Harsh Sharma CEO
 Chief Executive Officer 41 21-01-20
Deepak Sawant DFI
 Director of Finance/CFO 44 22-12-29
Aditi Himanshu Bhatt CMP
 Compliance Officer - 15-11-08

Members of the board

Members of the board TitleAgeSince
Subramanian R. Vaidya CHM
 Chairman 81 11-07-31
Vibha Gagan Sharma BRD
 Director/Board Member 40 08-07-28
Shruti Vishal Rao BRD
 Director/Board Member 39 06-07-26
Santosh Laxman Parab BRD
 Director/Board Member 53 16-05-23
Shilpa Bhatia BRD
 Director/Board Member 50 20-02-10
Gagan Harsh Sharma CEO
 Chief Executive Officer 41 21-01-20

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 104,690,822 36,280,834 ( 34.66 %) 0 34.66 %

Shareholders

NameEquities%Valuation
Shibroor Narasimha Kamath
30.53 %
31,957,024 30.53 % 43 M ₹
Arian Investment Ltd.
9.416 %
9,857,361 9.416 % 13 M ₹
Life Insurance Corporation of India (Investment Portfolio)
6.592 %
6,901,355 6.592 % 9 M ₹
Gulbarga Trading & Investments Pvt Ltd.
5.575 %
5,837,000 5.575 % 8 M ₹
Arjun Gautam Ashra
4.823 %
5,049,000 4.823 % 7 M ₹
Gautam Rasiklal Ashra
2.814 %
2,946,302 2.814 % 4 M ₹
Vibha Gagan Sharma
2.364 %
2,475,000 2.364 % 3 M ₹
Government of India
2.338 %
2,447,212 2.338 % 3 M ₹
Vaibhav Investments Ltd.
2.330 %
2,439,647 2.330 % 3 M ₹
Shruti Vishal Rao
2.015 %
2,110,000 2.015 % 3 M ₹

Company contact information

Bliss GVS Pharma Ltd.

102, Hyde Park Saki Vihar Road

400072, Mumbai

+91 22 4216 0000

http://www.blissgvs.com
address Bliss GVS Pharma Limited(BLISSGVS)

Group companies

NameCategory and Sector
Kremoint Pharma Pvt Ltd.
Logo Kremoint Pharma Pvt Ltd.

Kremoint Pharma Pvt Ltd.

Pharmaceuticals: MajorHealth Technology

Part of Bliss GVS Pharma Ltd., Kremoint Pharma Pvt Ltd. is an Indian company that manufactures and exports creams, ointments, and gels. The private company is based in Mumbai, India. The company was founded in 1994. Kremoint Pharma was acquired by Bliss GVS Pharma Ltd. on June 28, 2012.

Pharmaceuticals: Major

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Generic Pharmaceuticals

Sales per region

Sector Generic Pharmaceuticals

1st Jan change Capi.
BLISS GVS PHARMA LIMITED Stock Bliss GVS Pharma Limited
-1.81% 156M
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+20.29% 43.75B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+27.47% 22.06B
SANDOZ GROUP AG Stock Sandoz Group AG
+13.30% 14.46B
CIPLA LIMITED Stock Cipla Limited
+13.22% 13.62B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+39.17% 11.61B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-9.54% 6.9B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+9.64% 5.32B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. BLISSGVS Stock
  4. Company Bliss GVS Pharma Limited